Marrone Bio Innovations Stock Price, News & Analysis (NASDAQ:MBII)

$1.17 -0.06 (-4.88 %)
(As of 02/21/2018 02:18 AM ET)
Previous Close$1.23
Today's Range$1.16 - $1.25
52-Week Range$0.85 - $2.30
Volume73,700 shs
Average Volume98,524 shs
Market Capitalization$36.99 million
P/E Ratio-1.02
Dividend YieldN/A
Beta0.26

About Marrone Bio Innovations (NASDAQ:MBII)

Marrone Bio Innovations logoMarrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company's bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It offers Regalia for large-acre row crops, such as corn and soybeans. Its pipeline of early-stage discoveries and product candidates extends across a range of product types for end markets, including herbicides, fungicides, nematicides, insecticides, algaecides (for algae control), molluscicides (for mussel and snail control), and plant growth and plant stress regulators. It is engaged in developing MBI-010, MBI-110, Haven (MBI-505) and MBI-601.

Receive MBII News and Ratings via Email

Sign-up to receive the latest news and ratings for MBII and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Agricultural Chemicals
Sub-IndustryN/A
SectorBasic Materials
SymbolNASDAQ:MBII
CUSIPN/A
Phone+1-530-7502800

Debt

Debt-to-Equity Ratio-1.14%
Current Ratio0.69%
Quick Ratio0.36%

Price-To-Earnings

Trailing P/E Ratio-1.01739130434783
Forward P/E Ratio-1.10
P/E GrowthN/A

Sales & Book Value

Annual Sales$14.04 million
Price / Sales2.61
Cash FlowN/A
Price / CashN/A
Book Value($1.22) per share
Price / Book-0.96

Profitability

Trailing EPS($1.15)
Net Income$-31,070,000.00
Net Margins-178.77%
Return on EquityN/A
Return on Assets-72.00%

Miscellaneous

Employees38
Outstanding Shares31,350,000

Marrone Bio Innovations (NASDAQ:MBII) Frequently Asked Questions

What is Marrone Bio Innovations' stock symbol?

Marrone Bio Innovations trades on the NASDAQ under the ticker symbol "MBII."

How were Marrone Bio Innovations' earnings last quarter?

Marrone Bio Innovations Inc (NASDAQ:MBII) posted its quarterly earnings data on Tuesday, August, 9th. The basic materials company reported ($0.28) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.28). The basic materials company had revenue of $5 million for the quarter, compared to analyst estimates of $4.61 million. View Marrone Bio Innovations' Earnings History.

Where is Marrone Bio Innovations' stock going? Where will Marrone Bio Innovations' stock price be in 2018?

3 Wall Street analysts have issued twelve-month price objectives for Marrone Bio Innovations' stock. Their predictions range from $1.00 to $4.00. On average, they expect Marrone Bio Innovations' share price to reach $2.50 in the next twelve months. View Analyst Ratings for Marrone Bio Innovations.

Who are some of Marrone Bio Innovations' key competitors?

Who are Marrone Bio Innovations' key executives?

Marrone Bio Innovations' management team includes the folowing people:

  • Robert G. Woods, Chairman of the Board
  • James B. Boyd, President, Chief Financial Officer (Age 62)
  • Pamela G. Marrone Ph.D., Chief Executive Officer, Director (Age 59)
  • Linda V. Moore, Executive Vice President, General Counsel, Secretary (Age 69)
  • Brian R. Ahrens, Vice President of Sales (Age 44)
  • Nancy Hood, Vice President - Marketing (Age 55)
  • Timothy B. Johnson Ph.D., Vice President - Field Development and Technical Services (Age 59)
  • Keith J. Pitts, Vice President - Regulatory and Government Affairs (Age 52)
  • Amit Vasavada Ph.D., Vice President - Research and Development (Age 61)
  • Kathleen A. Merrigan Ph.D., Director (Age 56)

How do I buy Marrone Bio Innovations stock?

Shares of Marrone Bio Innovations can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Marrone Bio Innovations' stock price today?

One share of Marrone Bio Innovations stock can currently be purchased for approximately $1.17.

How big of a company is Marrone Bio Innovations?

Marrone Bio Innovations has a market capitalization of $36.99 million and generates $14.04 million in revenue each year. The basic materials company earns $-31,070,000.00 in net income (profit) each year or ($1.15) on an earnings per share basis. Marrone Bio Innovations employs 38 workers across the globe.

How can I contact Marrone Bio Innovations?

Marrone Bio Innovations' mailing address is 1540 Drew Ave, DAVIS, CA 95618-6320, United States. The basic materials company can be reached via phone at +1-530-7502800 or via email at [email protected]


MarketBeat Community Rating for Marrone Bio Innovations (MBII)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  88 (Vote Outperform)
Underperform Votes:  109 (Vote Underperform)
Total Votes:  197
MarketBeat's community ratings are surveys of what our community members think about Marrone Bio Innovations and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Marrone Bio Innovations (NASDAQ:MBII) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.332.332.332.33
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.50$2.50$2.50$2.50
Price Target Upside: 138.10% upside138.10% upside127.27% upside127.27% upside

Marrone Bio Innovations (NASDAQ:MBII) Consensus Price Target History

Price Target History for Marrone Bio Innovations (NASDAQ:MBII)

Marrone Bio Innovations (NASDAQ:MBII) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/21/2017HC WainwrightSet Price TargetBuy$4.00LowView Rating Details
7/22/2017Piper Jaffray CompaniesSet Price TargetHold$1.00HighView Rating Details
5/2/2017Jefferies GroupReiterated RatingHold$2.50LowView Rating Details
3/16/2016Rodman & RenshawInitiated CoverageBuy$3.50N/AView Rating Details
(Data available from 2/21/2016 forward)

Earnings

Marrone Bio Innovations (NASDAQ:MBII) Earnings History and Estimates Chart

Earnings by Quarter for Marrone Bio Innovations (NASDAQ:MBII)

Marrone Bio Innovations (NASDAQ MBII) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/13/2017Q3 2017($0.24)($0.27)$5.32 million$4.22 millionViewN/AView Earnings Details
8/14/2017Q2 2017($0.21)($0.25)$6.62 million$6.48 millionViewN/AView Earnings Details
5/11/2017Q1 2017($0.31)($0.31)$4.15 millionViewN/AView Earnings Details
3/29/2017Q4 2016($0.26)($0.32)$2.69 millionViewN/AView Earnings Details
11/14/2016Q316($0.22)($0.29)$4.61 million$3.63 millionViewN/AView Earnings Details
8/9/2016Q216($0.28)($0.28)$4.61 million$5.00 millionViewN/AView Earnings Details
5/12/2016Q116($0.27)($0.38)$3.05 million$2.70 millionViewListenView Earnings Details
3/30/2016Q215($0.40)($0.45)$1.10 million$1.90 millionViewListenView Earnings Details
11/17/2015Q3 2015($0.40)$2.48 millionViewN/AView Earnings Details
8/7/2014Q2 2014($0.49)($0.50)$7.59 million$3.63 millionViewN/AView Earnings Details
5/13/2014Q114($0.37)($0.52)$4.63 million$2.80 millionViewN/AView Earnings Details
3/6/2014Q4 2013($0.40)($0.52)$5.80 million$5.97 millionViewN/AView Earnings Details
11/7/2013Q3 2013($0.47)($0.53)$2.02 million$1.35 millionViewN/AView Earnings Details
9/12/2013Q2 2013($0.33)($2.36)$4.33 million$4.50 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Marrone Bio Innovations (NASDAQ:MBII) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.06 EPS
Next Year EPS Consensus Estimate: $-0.34 EPS

Dividends

Dividend History for Marrone Bio Innovations (NASDAQ:MBII)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Marrone Bio Innovations (NASDAQ MBII) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.80%
Institutional Ownership Percentage: 37.31%
Insider Trades by Quarter for Marrone Bio Innovations (NASDAQ:MBII)
Institutional Ownership by Quarter for Marrone Bio Innovations (NASDAQ:MBII)

Marrone Bio Innovations (NASDAQ MBII) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/5/2018Ardsley Advisory PartnersInsiderBuy6,666,667$0.75$5,000,000.25View SEC Filing  
2/1/2018Waddell & Reed Financial IncInsiderSell800$2.11$1,688.00View SEC Filing  
9/30/2017Waddell & Reed Financial IncInsiderBuy11,300$2.77$31,301.00View SEC Filing  
6/6/2017Waddell & Reed Financial IncInsiderBuy2,500,000$9.50$23,750,000.00View SEC Filing  
5/16/2017Waddell & Reed Financial IncInsiderBuy51,788$9.25$479,039.00View SEC Filing  
5/14/2017Waddell & Reed Financial IncInsiderBuy16,700$9.46$157,982.00View SEC Filing  
4/25/2017Ardsley Advisory PartnersMajor ShareholderBuy50,000$1.72$86,000.00View SEC Filing  
6/15/2016Richard E RomingerDirectorBuy10,000$0.94$9,400.003,836View SEC Filing  
6/13/2016James BoydCFOBuy10,000$0.79$7,900.005,000View SEC Filing  
6/9/2016George H KerckhoveDirectorBuy2,500$0.72$1,800.003,000View SEC Filing  
6/9/2016Pamela G MarroneCEOBuy5,000$0.72$3,600.00795,309View SEC Filing  
6/9/2016Timothy B JohnsonVPBuy10,000$0.72$7,200.0010,000View SEC Filing  
8/14/2014George H KerckhoveDirectorBuy400$5.90$2,360.00View SEC Filing  
8/12/2014Pamela G MarroneCEOBuy1,000$5.29$5,290.00View SEC Filing  
2/12/2014Ventures Pte. Ltd. Syngentamajor shareholderSell332,027$14.72$4,887,437.441,889,877View SEC Filing  
1/29/2014Donald GlidewellCFOSell75,495$17.00$1,283,415.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Marrone Bio Innovations (NASDAQ MBII) News Headlines

Source:
DateHeadline
Marrone Bio Innovations CEO: Its a wonderful time to be an entrepreneurMarrone Bio Innovations CEO: It's a wonderful time to be an entrepreneur
finance.yahoo.com - February 20 at 5:12 PM
Marrone Bio Innovations Announces The Netherlands as New Rapporteur Member State for SakaliaMarrone Bio Innovations Announces The Netherlands as New Rapporteur Member State for Sakalia
finance.yahoo.com - February 20 at 8:49 AM
Zacks Investment Research Lowers Marrone Bio Innovations (MBII) to SellZacks Investment Research Lowers Marrone Bio Innovations (MBII) to Sell
www.americanbankingnews.com - February 17 at 8:12 PM
Marrone Bio Innovations Inc Forecasted to Post FY2017 Earnings of ($1.10) Per Share (MBII)Marrone Bio Innovations Inc Forecasted to Post FY2017 Earnings of ($1.10) Per Share (MBII)
www.americanbankingnews.com - February 12 at 1:08 AM
Jefferies Group Weighs in on Marrone Bio Innovations Incs FY2022 Earnings (MBII)Jefferies Group Weighs in on Marrone Bio Innovations Inc's FY2022 Earnings (MBII)
www.americanbankingnews.com - February 9 at 6:14 PM
Waddell & Reed Financial Inc Purchases 11,300 Shares of Marrone Bio Innovations Inc (MBII) StockWaddell & Reed Financial Inc Purchases 11,300 Shares of Marrone Bio Innovations Inc (MBII) Stock
www.americanbankingnews.com - February 8 at 4:02 AM
Marrone Bio Innovations Inc (MBII) Insider Waddell & Reed Financial Inc Purchases 16,700 SharesMarrone Bio Innovations Inc (MBII) Insider Waddell & Reed Financial Inc Purchases 16,700 Shares
www.americanbankingnews.com - February 8 at 12:46 AM
Insider Buying: Marrone Bio Innovations Inc (MBII) Insider Purchases 51,788 Shares of StockInsider Buying: Marrone Bio Innovations Inc (MBII) Insider Purchases 51,788 Shares of Stock
www.americanbankingnews.com - February 8 at 12:30 AM
Marrone Bio Innovations Inc (MBII) Insider Acquires $23,750,000.00 in StockMarrone Bio Innovations Inc (MBII) Insider Acquires $23,750,000.00 in Stock
www.americanbankingnews.com - February 8 at 12:10 AM
Marrone Bio clears away most debt, gets a new chairmanMarrone Bio clears away most debt, gets a new chairman
finance.yahoo.com - February 7 at 9:31 AM
Insider Buying: Marrone Bio Innovations Inc (MBII) Insider Purchases 6,666,667 Shares of StockInsider Buying: Marrone Bio Innovations Inc (MBII) Insider Purchases 6,666,667 Shares of Stock
www.americanbankingnews.com - February 6 at 12:24 PM
Marrone Bio Innovations, Inc. Announces Closing of Private Placement and Debt Refinancing TransactionsMarrone Bio Innovations, Inc. Announces Closing of Private Placement and Debt Refinancing Transactions
finance.yahoo.com - February 6 at 9:23 AM
Marrone Bio Innovations (MBII) Lifted to Sell at ValuEngineMarrone Bio Innovations (MBII) Lifted to Sell at ValuEngine
www.americanbankingnews.com - February 4 at 10:48 PM
Marine Bio (MBII) Announces Stockholder Approval of Private Placement, Debt Refinance TransactionsMarine Bio (MBII) Announces Stockholder Approval of Private Placement, Debt Refinance Transactions
www.streetinsider.com - February 2 at 4:19 PM
Haven® Sun Protectant Approved in CaliforniaHaven® Sun Protectant Approved in California
finance.yahoo.com - January 30 at 9:56 AM
Marrone Bio Innovations Announces Distribution Partnership in the PhilippinesMarrone Bio Innovations Announces Distribution Partnership in the Philippines
finance.yahoo.com - January 25 at 9:25 AM
Marrone Bio Innovations Announces the Launch of Zelto™ for Control of Foliar and Soil Dwelling Pests on TurfMarrone Bio Innovations Announces the Launch of Zelto™ for Control of Foliar and Soil Dwelling Pests on Turf
finance.yahoo.com - January 17 at 9:02 AM
Marrone Bio Innovations Announces Availability of Next Generation Grandevo® WDG Bioinsecticide in CaliforniaMarrone Bio Innovations Announces Availability of Next Generation Grandevo® WDG Bioinsecticide in California
finance.yahoo.com - January 10 at 9:19 AM
Was Marrone Bio Innovations Inc’s (NASDAQ:MBII) Earnings Growth Better Than Industry?Was Marrone Bio Innovations Inc’s (NASDAQ:MBII) Earnings Growth Better Than Industry?
finance.yahoo.com - December 30 at 9:09 AM
Marrone Bio Innovations (MBII) Given a $4.00 Price Target by HC Wainwright AnalystsMarrone Bio Innovations (MBII) Given a $4.00 Price Target by HC Wainwright Analysts
www.americanbankingnews.com - December 21 at 1:00 PM
Marrone Bio Innovations and DISAGRO Sign Exclusive Distribution Agreement for REGALIA® Maxx Biofungicide in Central AmericaMarrone Bio Innovations and DISAGRO Sign Exclusive Distribution Agreement for REGALIA® Maxx Biofungicide in Central America
finance.yahoo.com - December 20 at 9:13 AM
Marrone Bio enters deal to reduce debt by 72 percentMarrone Bio enters deal to reduce debt by 72 percent
finance.yahoo.com - December 19 at 5:33 PM
BRIEF-Marrone Bio Innovations, Inc. Announces Comprehensive Financing And Debt Restructuring TransactionBRIEF-Marrone Bio Innovations, Inc. Announces Comprehensive Financing And Debt Restructuring Transaction
www.reuters.com - December 18 at 9:25 AM
Marrone Bios Amplitude Available for 2018 Growing SeasonMarrone Bio's Amplitude Available for 2018 Growing Season
www.zacks.com - December 14 at 9:18 AM
Marrone Bio's Amplitude Available for 2018 Growing SeasonMarrone Bio's Amplitude Available for 2018 Growing Season
finance.yahoo.com - December 14 at 9:18 AM
Marrone Bio Innovations Announces the Availability of Amplitude™ Biofungicide for White Mold Control in the 2018 Growing SeasonMarrone Bio Innovations Announces the Availability of Amplitude™ Biofungicide for White Mold Control in the 2018 Growing Season
finance.yahoo.com - December 8 at 9:12 AM
Marrone Bio Innovations Adds Three Commercial Managers for Southeast, West Coast, and Northeast and Mid-Atlantic RegionsMarrone Bio Innovations Adds Three Commercial Managers for Southeast, West Coast, and Northeast and Mid-Atlantic Regions
finance.yahoo.com - December 4 at 9:09 AM
ETFs with exposure to Marrone Bio Innovations, Inc. : November 30, 2017ETFs with exposure to Marrone Bio Innovations, Inc. : November 30, 2017
finance.yahoo.com - November 30 at 5:34 PM
Marrone Bio Innovations, Inc. :MBII-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017Marrone Bio Innovations, Inc. :MBII-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
finance.yahoo.com - November 29 at 9:14 AM
Marrone Bio Innovations, Inc. to Present at 10th Annual LD Micro Main Event Investor Conference in Los AngelesMarrone Bio Innovations, Inc. to Present at 10th Annual LD Micro Main Event Investor Conference in Los Angeles
finance.yahoo.com - November 22 at 2:53 AM
Marrone Bio stock jumps 24 percent as sales increaseMarrone Bio stock jumps 24 percent as sales increase
finance.yahoo.com - November 17 at 3:18 PM
Edited Transcript of MBII earnings conference call or presentation 13-Nov-17 9:30pm GMTEdited Transcript of MBII earnings conference call or presentation 13-Nov-17 9:30pm GMT
finance.yahoo.com - November 15 at 6:12 AM
Marrone Bio Innovations, Inc. to Host Earnings CallMarrone Bio Innovations, Inc. to Host Earnings Call
finance.yahoo.com - November 14 at 2:58 AM
Marrone Bio Innovations, Inc. Reports Third Quarter 2017 Financial ResultsMarrone Bio Innovations, Inc. Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 14 at 2:58 AM
New Marrone Bio product gets EPA approvalNew Marrone Bio product gets EPA approval
finance.yahoo.com - November 2 at 6:14 AM
Marrone Bio Innovations to Report Third Quarter 2017 Financial Results and Host a Conference Call on Monday, November 13th at 1:30 p.m. Pacific timeMarrone Bio Innovations to Report Third Quarter 2017 Financial Results and Host a Conference Call on Monday, November 13th at 1:30 p.m. Pacific time
finance.yahoo.com - October 31 at 3:34 AM
Marrone Bio Innovations Receives EPA Approval for Novel BiofungicideMarrone Bio Innovations Receives EPA Approval for Novel Biofungicide
finance.yahoo.com - October 31 at 3:34 AM
BRIEF-Marrone Bio signs exclusive agreement with Kenya BiologicsBRIEF-Marrone Bio signs exclusive agreement with Kenya Biologics
www.reuters.com - October 19 at 6:09 AM
Marrone Bio Innovations Signs Exclusive Distribution Agreement with Kenya Biologics Ltd. for Kenya and TanzaniaMarrone Bio Innovations Signs Exclusive Distribution Agreement with Kenya Biologics Ltd. for Kenya and Tanzania
finance.yahoo.com - October 19 at 6:09 AM
Comparing Israel Chemicals Shs (ICL) and Marrone Bio Innovations (MBII)Comparing Israel Chemicals Shs (ICL) and Marrone Bio Innovations (MBII)
www.americanbankingnews.com - October 15 at 6:26 AM
Marrone Bio Innovations (MBII) & Its Peers Critical AnalysisMarrone Bio Innovations (MBII) & Its Peers Critical Analysis
www.americanbankingnews.com - October 11 at 4:24 PM
Marrone Bio Innovations, Inc. Receives Positive Results From Brazil TrialsMarrone Bio Innovations, Inc. Receives Positive Results From Brazil Trials
finance.yahoo.com - October 11 at 3:19 PM
Head to Head Survey: Marrone Bio Innovations (MBII) and The CompetitionHead to Head Survey: Marrone Bio Innovations (MBII) and The Competition
www.americanbankingnews.com - October 11 at 2:20 PM
All You Need To Know About Marrone Bio Innovations Inc’s (MBII) RisksAll You Need To Know About Marrone Bio Innovations Inc’s (MBII) Risks
finance.yahoo.com - October 6 at 10:16 AM
Marrone Bio Innovations to Present at The MicroCap Conference in New York on October 5thMarrone Bio Innovations to Present at The MicroCap Conference in New York on October 5th
www.nasdaq.com - September 29 at 6:43 PM
Marrone Bio Innovations to Present at The MicroCap Conference in New York on October 5th - GlobeNewswire (press release)Marrone Bio Innovations to Present at The MicroCap Conference in New York on October 5th - GlobeNewswire (press release)
globenewswire.com - September 29 at 1:42 PM
Marrone Bio (MBII), Elephant Vert Ink Distribution DealMarrone Bio (MBII), Elephant Vert Ink Distribution Deal
finance.yahoo.com - September 25 at 7:18 PM
Marrone Bio Innovations Announces Availability of Venerate XC Bioinsecticide Product in New YorkMarrone Bio Innovations Announces Availability of Venerate XC Bioinsecticide Product in New York
finance.yahoo.com - September 25 at 8:33 AM
Marrone Bio Innovations (MBII) vs. Israel Chemicals Shs (ICL) Head-To-Head ContrastMarrone Bio Innovations (MBII) vs. Israel Chemicals Shs (ICL) Head-To-Head Contrast
www.americanbankingnews.com - September 24 at 2:48 PM
Reviewing Israel Chemicals Shs (ICL) & Marrone Bio Innovations (MBII)Reviewing Israel Chemicals Shs (ICL) & Marrone Bio Innovations (MBII)
www.americanbankingnews.com - September 19 at 2:48 PM

SEC Filings

Marrone Bio Innovations (NASDAQ:MBII) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Marrone Bio Innovations (NASDAQ:MBII) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Marrone Bio Innovations (NASDAQ MBII) Stock Chart for Wednesday, February, 21, 2018

Loading chart…

This page was last updated on 2/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.